Case Law Update
prescribing practices

This issue of NAMSDL Case Law Update focuses on several ongoing cases related to the marketing, distribution and prescribing of controlled substances. Summarized cases include: (1) a lawsuit recently filed against the maker of OxyContin by a city in Washington State and (2) a federal appellate court decision upholding a doctor’s conviction for Controlled Substances Act violations. The next issues of the Case Law Update will focus on cases involving drugged driving, marijuana and novel psychoactive substances. Read more »

Case Law Caselaw Issue Newsletter Opioid OxyContin Pharmaceutical manufacturer prescribing practices Prescription drug abuse Suspicious order Update